Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the Egyptian National Cancer Institute|October 18, 2018
Axillary metastasis in clinically node-negative breast cancerOrhan Üreyen, Demet Kocatepe Çavdar, Zehra Hilal Adıbelli, et al.
European Journal of Breast Health|April 21, 2022
Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer PatientsÖzlem Özdemir, Baha Zengel, Demet Kocatepe Çavdar, et al.
Breast Cancer (Dove Medical Press)|January 6, 2025
Correlation of Histopathological and Radiological Response Patterns and Their Prognostic Implications in Breast Cancer After Neoadjuvant ChemotherapyAhmet Bozer, Cengiz Yilmaz, Hülya Çetin Tunçez, et al.
Magnetic Resonance in Medical Sciences : MRMS : an Official Journal of Japan Society of Magnetic Resonance in Medicine|March 16, 2025
MR Imaging Features Predictive of Pathologic Complete Response and Survival Outcomes for Breast Cancer Patients Undergoing Neoadjuvant ChemotherapyAhmet Bozer, Cengiz Yilmaz, Hülya Çetin Tunçez, et al.
Breast Cancer (Dove Medical Press)|March 20, 2026
Radiological and Histopathological Predictors of Survival in Neuroendocrine Differentiated Breast Cancer: A Comparative Analysis with NS-IDCHülya Çetin Tunçez, Zehra Hilal Adibelli, Nebil Havvat, et al.
Pediatric Nephrology (Berlin, Germany)|January 26, 2026
T-cell lymphoblastic lymphoma presenting with type B lactic acidosis and acute kidney injury in an adolescentPelin Abdal Yıldırım, Seçil Arslansoyu Çamlar, Demet Kocatepe Çavdar, et al.
Diagnostics (Basel, Switzerland)|July 29, 2025
Can Mammography and Magnetic Resonance Imaging Predict the Preoperative Size and Nuclear Grade of Pure Ductal Carcinoma In Situ?Hülya Çetin Tunçez, Merve Gürsoy Bulut, Zehra Hilal Adıbelli, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)|October 27, 2025
Magnetic resonance imaging-based artificial intelligence model predicts neoadjuvant therapy response in triple-negative breast cancerRaşit Eren Büyüktoka, Zehra Hilal Adıbelli, Murat Sürücü, et al.
Cancers|January 25, 2025
A Comprehensive Analysis of Neoadjuvant Chemotherapy in Breast Cancer: Adverse Events, Clinical Response Rates, and Surgical and Pathological Outcomes-Bozyaka ExperienceCengiz Yılmaz, Baha Zengel, Orhan Üreyen, et al.
Pageof 1